2013 Hyperthermia / Hypothermia Outcomes 
Pediatric EM Morsels
AUGUST 9, 2024
We have previously discussed hypothermia presentations , GBS infections , and HSV infections. Foles, 2024 ] In the US, from 2013-2018, cases increased from 362 to 1,306. If not treated early, then increased risk of poor outcomes and death. 2013 Aug;20(4):337-9. Epub 2013 Feb 27. BMJ Case Rep. Emerg Radiol.
PulmCCM
JANUARY 22, 2024
Background Therapeutic hypothermia, later rebranded as targeted temperature management, became a standard post-cardiac arrest therapy for comatose patients after two 2002 NEJM trials ( n=273 and n=77 ) suggested reducing core temperature to 32°C to 34°C markedly improved neurologic outcomes and survival.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EMDocs
DECEMBER 18, 2024
2013; 88(9): 589-595. Alcohol withdrawal syndrome: improving outcomes through early identification and aggressive treatment strategies. fold higher risk of NSTI than the control group 12 For those without comorbidities , AUD exhibited a 15.2-fold Alcohol withdrawal syndrome in medical patients. Cleve Clin J Med. 2016; 83(1): 67-79.
The Skeptics' Guide to EM
JULY 3, 2021
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. Background: Hypothermia has been a mainstay of post-arrest care after the publication of two trials in 2002 that both suggested a benefit. This gives a NNT of 4.
ACEP Now
APRIL 3, 2024
Early work on TTM in 2002 showed benefit to cooling to 33 degrees Celsius, which subsequently influenced international resuscitation guidelines to recommend mild hypothermia at 32 degrees to 34 degrees Celsius in 2005. degrees Celsius. 5,6 In 2021, the TTM2 trial was published. degrees Celsius for 72 hours.
PulmCCM
JANUARY 24, 2024
Background Therapeutic hypothermia, later rebranded as targeted temperature management, became a standard post-cardiac arrest therapy for comatose patients after two 2002 NEJM trials ( n=273 and n=77 ) suggested reducing core temperature to 32°C to 34°C markedly improved neurologic outcomes and survival.
The Skeptics' Guide to EM
MAY 8, 2021
Improving outcomes for patients with cardiac arrests has been an ongoing challenge in pre-hospital and in hospital medicine. SGEM#50 looked at a RCT published in JAMA 2013 looking to see if a vasopressin, steroids, and epinephrine (VSE) protocol for IHCAs could improve survival with favorable neurologic outcome compared to epinephrine alone.
Expert insights. Personalized for you.
.jpg)
152 
Let's personalize your content